13th International Bordetella Symposium

第13届国际博德特氏菌研讨会

• 批准号: 10506485
• 负责人: Fredrick Heath Damron
• 金额: $ 1.5万
• 依托单位: WEST VIRGINIA UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-04-01 至 2023-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10506485
• 关键词: 13th; International; Bordetella; Symposium

Project Summary/Abstract: Whooping cough, also known as Pertussis, is a respiratory disease caused by the bacterial pathogen Bordetella pertussis. Pertussis is one of the world’s leading causes of vaccine-preventable deaths and is currently the only vaccine-preventable bacterial disease that is increasing in incidence. Despite high vaccine coverage, whooping cough (pertussis) has re-emerged as a major public health concern in the US and the world. Recently, it was estimated that there were 24 million pertussis cases and 160,700 deaths in children younger than 5 years around the world per year. In addition to being added to the NIH emerging infectious pathogens list in 2015, the CDC recently listed Bordetella pertussis on its new Watch List in the 2019 Antibiotic Resistance Threats Report because of the unknown future burden of this highly contagious bacterium. Since the 1960’s, the Bordetella research community has organized an International Bordetella Symposium, the 12th symposium was hosted at Brussels University by Dr. Camille Locht, in April of 2019. In an effort to increase dissemination of new data and exchange of ideas, Dr. Ciaran Skerry hosted the 1st ever Bordetella Research Day at the University of Maryland in April, 2018. The Bordetella Research Day was meant to be a U.S-based conference for Bordetella researchers to meet during the off years of the International Bordetella Symposiums. Due to the COVID-19 pandemic, both the 2020 Bordetella Research Day, and the 2021 International Bordetella Symposium were postponed. To continue dissemination of important research, the International Bordetella Society hosted a zoom-based conference in August 2020 which garnered attendance from academia, the CDC, FDA, NIH, and many pharmaceutical companies. The major success of this online event resulted in the Bordetella Society creating a monthly Lab Meeting Series, where different groups around the world can showcase their latest research. In order to further support the development of the next generation of scientists, this R13 application is requesting funds from the FDA Center for Biologics Evaluations and Research (CBER) to support travel associated costs for junior scientists (pre- and post-doctoral) to attend and present innovative research at the 13th International Bordetella Symposium hosted at the University of British Columbia in Vancouver, Canada (June 2022).

项目摘要/摘要： 百日咳，也称为百日咳，是一种由细菌病原体博德特氏菌引起的呼吸道疾病 百日咳。百日咳是世界上疫苗可预防的死亡的主要原因之一，也是目前唯一的 疫苗可预防的细菌性疾病的发病率正在增加。尽管疫苗覆盖率很高，但百日咳 咳嗽（百日咳）已重新成为美国和世界的主要公共卫生问题。最近，它是 据估计，大约有 2,400 万例百日咳病例，其中 160,700 例 5 岁以下儿童死亡 每年的世界。除了 2015 年被添加到 NIH 新发传染性病原体清单中外，CDC 最近将百日咳博德特氏菌列入 2019 年抗生素耐药性威胁报告的新观察名单 因为这种高度传染性细菌的未来负担未知。自 20 世纪 60 年代以来，博德特氏菌 研究界组织了国际博德特氏菌研讨会，第12届研讨会在 布鲁塞尔大学，作者：Camille Locht 博士，2019 年 4 月。为了加强新数据和 交流思想，Ciaran Skerry 博士在马里兰大学主持了第一届博德特氏菌研究日活动 2018 年 4 月。博德特氏菌研究日原本是为博德特氏菌研究人员在美国举办的会议 在国际博德特氏菌研讨会休会期间举行。由于 COVID-19 大流行， 2020年博德特氏菌研究日和2021年国际博德特氏菌研讨会被推迟。到 继续传播重要研究成果，国际博德特氏菌协会主办了基于变焦的 2020 年 8 月举行的会议吸引了学术界、疾病预防控制中心 (CDC)、FDA、美国国立卫生研究院 (NIH) 和许多机构的参加 制药公司。这次在线活动取得了巨大成功，博德特氏菌协会创建了一个 每月一次的实验室会议系列，世界各地的不同团体可以展示他们的最新研究成果。在 为了进一步支持下一代科学家的发展，这个R13应用程序要求 FDA 生物制品评估和研究中心 (CBER) 提供的资金用于支持差旅相关费用 供青年科学家（博士前和博士后）参加第 13 届国际会议并展示创新研究 Bordetella 研讨会在加拿大温哥华不列颠哥伦比亚大学主办（2022 年 6 月）。